Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer
Kathleen M. McAndrews, Fei Xiao, Antonios Chronopoulos, et al.
Life Science Alliance (2021) Vol. 4, Iss. 9, pp. e202000875-e202000875
Open Access | Times Cited: 134

Showing 26-50 of 134 citing articles:

Harnessing exosomes as cancer biomarkers in clinical oncology
Subhrojyoti Ghosh, Ramya Lakshmi Rajendran, Atharva Anand Mahajan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells
Dong Hu, Ruyue Yang, Guidan Wang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2773-2791
Open Access | Times Cited: 10
Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies
Mehrnoosh Bahadorani, Mahboobeh Nasiri, Kristen Dellinger, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7137-7164
Open Access | Times Cited: 9
Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9
Minse Kim, Youngwoo Hwang, Seongyu Lim, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1197-1197
Open Access | Times Cited: 9
Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics
Xiaohong Li, Yuting Wei, Zhirang Zhang, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2024) Vol. 5, Iss. 1, pp. 44-63
Open Access | Times Cited: 8
Advancements in Colorectal Cancer Immunotherapy: From CAR-T Cells to Exosome-Based Therapies
Sepideh Arabi, Manouchehr Fadaee, Tohid Kazemi, et al.
Journal of drug targeting (2025), pp. 1-23
Closed Access | Times Cited: 1
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 1
CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations
Ali Hazrati, Kosar Malekpour, Sara Soudi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113943-113943
Closed Access | Times Cited: 35
Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
Nasir Uddin, Daniel W. Binzel, Dan Shu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1383-1399
Open Access | Times Cited: 34
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
Annalisa Comandatore, Benoît Immordino, Rita Balsano, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 286-286
Open Access | Times Cited: 29
Progress of delivery methods for CRISPR-Cas9
Wu Yang, Jiaqi Yan, Pengzhen Zhuang, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 8, pp. 913-926
Open Access | Times Cited: 29
Gene Therapy Strategies Targeting Aging-Related Diseases
Jingyu Yu, Tianwen Li, Jianhong Zhu
Aging and Disease (2022)
Open Access | Times Cited: 28
Optimization of exosome-based cell-free strategies to enhance endogenous cell functions in tissue regeneration
Siyan Deng, Hongfu Cao, Xiaolin Cui, et al.
Acta Biomaterialia (2023) Vol. 171, pp. 68-84
Open Access | Times Cited: 21
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 21
Bioengineered nanotechnology for nucleic acid delivery
Yang Zhang, Jing Luo, Xiran Gui, et al.
Journal of Controlled Release (2023) Vol. 364, pp. 124-141
Open Access | Times Cited: 21
Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications
Sofia Shtykalova, Dmitriy Deviatkin, Svetlana Freund, et al.
Life (2023) Vol. 13, Iss. 4, pp. 903-903
Open Access | Times Cited: 17
Viral Vectors, Exosomes, and Vexosomes: Potential armamentarium for delivering CRISPR/Cas to cancer cells
Mahdieh Farzanehpour, Ali Miri, Akbar Ghorbani Alvanegh, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115555-115555
Closed Access | Times Cited: 17
CRISPR/Cas9-based gene-editing technology for sickle cell disease
Liangliang Ma, Shanglun Yang, Qianya Peng, et al.
Gene (2023) Vol. 874, pp. 147480-147480
Closed Access | Times Cited: 17
Peptide-based PROTACs: Current Challenges and Future Perspectives
Huidan Wang, Miao Chen, Xiaoyuan Zhang, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 2, pp. 208-222
Closed Access | Times Cited: 16
Advances in exosomes utilization for clinical applications in cancer
Inês A. Batista, José Carlos Machado, Sónia A. Melo
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 947-968
Closed Access | Times Cited: 7
Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles
Zhidu Song, Tao Ying, Yue Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases
Gabriele Zanirati, Paula Gabrielli dos Santos, Allan Marinho Alcará, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7371-7371
Open Access | Times Cited: 6
Exosomes: the key of sophisticated cell–cell communication and targeted metastasis in pancreatic cancer
Huan Zhang, Juan Xing, Zhujiang Dai, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 26
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Advancements in engineered exosomes for wound repair: current research and future perspectives
Hailian Ye, Feng Wang, Guangchao Xu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 16

Scroll to top